# U.S. resumes COVID-19 vaccine orders after unexplained delay States can now order vaccines amid concerns over political interference. - **Source:** [Ars Technica - All content](https://brifing.si/source/b728770c-8dda-457a-8986-84879c9fc42c) - **Published:** 2026-09-24 - **Topic:** [Business](https://brifing.si/c/business) - **Original article:** - **On Brifing:** https://brifing.si/s/498966c1-094c-4ed7-afb0-331a758d9182 ## Vaccine ordering resumes After a month-long delay, states can now order COVID-19 vaccines through the federal Vaccines for Children program. This initiative provides free immunizations to low-income children. The delay had raised concerns about potential political interference. The CDC had not opened ordering despite FDA approval in late August. ## Unclear reasons for delay Trump administration officials have not provided a clear explanation for the delay. Health Secretary Robert F. Kennedy Jr., known for anti-vaccine views, is suspected of involvement. The CDC stated it hadn't finalized procurement decisions. HHS emphasized responsible use of taxpayer funds for vaccines. ## Program eligibility questioned Federal officials appear to be debating whether children should receive these vaccines through the program. The Vaccines for Children program serves low-income populations. HHS stressed ensuring vaccines are appropriate for program recipients. This hesitation comes despite FDA approval of the vaccines. ## Political context The delay occurs amid heightened political tensions around vaccination policies. Anti-vaccine sentiment has grown in certain political circles. The situation reflects broader debates about public health authority. Such delays could impact vaccination timelines for vulnerable populations. ## Program importance The Vaccines for Children program is crucial for equitable vaccine access. It serves approximately 40% of American children. Delays in vaccine distribution disproportionately affect low-income families. The program has operated successfully for decades with bipartisan support. ## Regulatory approval status The FDA approved the 2026-2027 COVID-19 vaccines in late August. Despite approval, CDC hadn't opened ordering until recently. This gap between approval and distribution is unusual. Typically, vaccines become available shortly after regulatory clearance. ## Potential consequences Delays could disrupt vaccination schedules before flu season. Late immunization may reduce community protection levels. Public health experts warn about preventable disease outbreaks. The situation may erode trust in vaccination programs. ## Ongoing scrutiny Public health advocates are monitoring the situation closely. Further delays could prompt congressional inquiries. The episode highlights vulnerabilities in vaccine distribution systems. Transparency about decision-making processes remains a key concern. ## Sources covering this story - https://arstechnica.com/health/2026/09/cdc-opens-state-ordering-for-covid-19-vaccines-after-unexplained-delay/ — --- _Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._